SeekingAlpha Fulgent Genetics: Core Growth Re-Acceleration Will Be The Critical Catalyst...\n more…
Ticker Report Fulgent Genetics, Inc. (NASDAQ:FLGT - Get Free Report) CEO Ming Hsieh sold 2,313 shares of the company's stock in a transaction that occurred on Tuesday, August 27th. The stock was sold at an average...\n more…
Ticker Report SG Americas Securities LLC raised its position in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) by 36.4% in the 2nd quarter, according to the company in its most recent disclosure with...\n more…
Ticker Report Aclarion (NASDAQ:ACON - Get Free Report) and Fulgent Genetics (NASDAQ:FLGT - Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two...\n more…
Market News Video In trading on Monday, shares of Fulgent Genetics Inc (FLGT) crossed above their 200 day moving average of 23.72, changing hands as high as 23.84 per share. Fulgent Genetics Inc shares are...\n more…
Ticker Report TCW Group Inc. grew its stake in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) by 3.0% in the second quarter, according to the company in its most recent Form 13F filing with the SEC...\n more…